Download
1 / 3
30 likes | 38 Views
UK Gravesu2019 disease market is growing at a CAGR of around 4.1% during the forecast period. Graveu2019s<br>UK Gravesu2019 disease market is growing at a CAGR of around 4.1% during the forecast period. Graveu2019s disease is one of the most prevalent autoimmune diseases across the UK. It is one of the leading causes of hyperthyroidism in the country. The disease is caused by a number of factors including the sedentary lifestyles, changing eating pattern, the prevalence of diabetes in the country are few of the key reasons which are expected to promote the demand of treatment and diagnostic services, which in turn increases the UK Gravesu2019 disease market. The prevalence of diabetes has increased significantly in the UK. According to The British Diabetic Association 2017, nearly 3.7 million people were diagnosed with diabetes. Amongst this 10 %, people have type-1 diabetes. As the prevalence of such disease increases in the country, the risk associated with Graveu2019s disease is also increasing, thereby creating opportunities for the growth of the UK Gravesu2019 disease market during the forecast period. lifestyles, changing eating pattern, the prevalence of diabetes in the country are few of the key reasons<br>which are expected to promote the demand of treatment and diagnostic services, which in turn<br>increases the UK Gravesu2019 disease market. The prevalence of diabetes has increased significantly in the<br>UK. According to The British Diabetic Association 2017, nearly 3.7 million people were diagnosed with<br>diabetes. Amongst this 10 %, people have type-1 diabetes. As the prevalence of such disease increases<br>in the country, the risk associated with Graveu2019s disease is also increasing, thereby creating opportunities<br>for the growth of the UK Gravesu2019 disease market during the forecast period.
E N D
Orion Market Research UK Graves’ disease Market Size, Segmentation, Share, Forecast, Analysis, Industry Report to 2025 Request a Free Sample of our Report on UK Graves’ disease Market @ https://www.omrglobal.com/request-sample/uk-graves-disease-market ------------------------------------------------------------------------------------ Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 7803040404
UK Graves’ disease market is growing at a CAGR of around 4.1% during the forecast period. Grave’s disease is one of the most prevalent autoimmune diseases across the UK. It is one of the leading causes of hyperthyroidism in the country. The disease is caused by a number of factors including the sedentary lifestyles, changing eating pattern, the prevalence of diabetes in the country are few of the key reasons which are expected to promote the demand of treatment and diagnostic services, which in turn increases the UK Graves’ disease market. The prevalence of diabetes has increased significantly in the UK. According to The British Diabetic Association 2017, nearly 3.7 million people were diagnosed with diabetes. Amongst this 10 %, people have type-1 diabetes. As the prevalence of such disease increases in the country, the risk associated with Grave’s disease is also increasing, thereby creating opportunities for the growth of the UK Graves’ disease market during the forecast period. Request a Free Sample of our Report on UK Graves’ disease Market @ https://www.omrglobal.com/request-sample/uk-graves-disease-market Further, the prevalence of Grave’s’ disease is majorly amongst the age group of 19-54. According to Eurostat, the working-age population in the UK accounted for 64.4% of the overall population. The prevalence of Grave’s disease also increases with changes in unhealthy eating patterns and smoking practices. It is observed that smoking is one of the key reasons which promote the prevalence of Grave’s disease in the working-age population. The percentage of population smoking in the UK is majorly between the age group of 25-34. Owing to this, the prevalence of Grave’s disease is expected to increase, thereby creating opportunities for the growth of the UK Graves’ disease market. A full Report of UK Graves’ disease Market is Available at: https://www.omrglobal.com/industry- reports/uk-graves-disease-market UK Graves’ Disease Market Segmentation By Diagnosis • Ultrasound • Imaging Tests • Radioactive Iodine Uptake • Blood Sample
By Treatment • Anti- Thyroid Medication • Radioactive Iodine Therapy • Surgery Company Profiles • Abbott Laboratories Inc. • Allergan PLC • Eli Lilly and Co. • GlaxoSmithKline PLC • Johnson & Johnson • Merck & Co. Inc. • Mylan NV • Novartis International AG • Pfizer Inc. • Sanofi SA For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report- customization/uk-graves-disease-market About us: Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research- based services. For More Information, Visit https://www.omrglobal.com/ Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 780-304-0404
